Patient-derived gastric cancer samples have been shown to express phosphorylated mTOR indicative of mTOR activation [8–11], which has been positively correlated with tumor progression and poor survival in patients with gastric cancer [9, 11, 12]. The gene discussed is MTOR; the disease is gastric cancer.